Company Description Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Associate Safety Director m/f/d, Basel-Stadt Job Profil (2YOG38) Life Sciences - Clinical & Safety Basel-Stadt Contracting Vollzeit ASAP (latest ) - pharmacovigilance, Drug safety, Signal detection, Clinical Operations We are currently looking for an experienced Associate
Associate Safety Director (m/f/d) Freelance/Contracting project Basel Stadt Start date: 08/26 Reference number: /1 Diesen Job teilen oder drucken Responsibilities Responsible for individual and aggregate case reporting activities including ICSR case management (medical review) and aggregate reporting (
Associate Safety Director (m/f/d) (LSW)- Drug safety/pharmacovigilance/ English Background: Portfolio Safety Scientists (PCS-Sci) provide safety science and pharmacovigilance support to molecules across the Roche portfolio. As a group, they are responsible for all aspects of safety
Turn safety data into smarter decisions that protect patients worldwide. Proclinical is seeking an Associate Safety Director to join a dynamic team in Switzerland. This role focuses on providing safety science and pharmacovigilance expertise across the
Who We Are TetraScience is the Scientific Data and AI Cloud company. We are catalyzing the Scientific AI revolution by designing and industrializing AI‑native scientific data sets, which we bring to life in a growing suite